Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer
Roberto Méndez, Kousik Kesh, Nivedita Arora, et al.
Carcinogenesis (2019) Vol. 41, Iss. 5, pp. 561-570
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer
Zhengting Jiang, Wenjie Zhang, Zhilin Zhang, et al.
Cancer Letters (2022) Vol. 554, pp. 216031-216031
Closed Access | Times Cited: 28
Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target
Tao Zhang, Guangqi Gao, Hafiz Arbab Sakandar, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 25
Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response
Yihan Chai, Zhengze Huang, Xuqiu Shen, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1240-1240
Open Access | Times Cited: 16
Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation
Jessica Queen, Fyza Y. Shaikh, Cynthia L. Sears
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1083-1094
Closed Access | Times Cited: 15
The Role of Microbiota in Pancreatic Cancer
Valerio Papa, Tommaso Schepis, Gaetano Coppola, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3143-3143
Open Access | Times Cited: 13
Emerging implications of bacterial biofilm in cancer biology: Recent updates and major perspectives
Manish Kushwaha, Vanditha Nukala, Akhilesh Kumar Singh, et al.
Gut Microbes Reports (2024) Vol. 1, Iss. 1, pp. 1-20
Open Access | Times Cited: 5
Gut microbiota in pancreatic diseases: possible new therapeutic strategies
Li‐Long Pan, Binbin Li, Xiaohua Pan, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 7, pp. 1027-1039
Open Access | Times Cited: 39
Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients
Lidia Sánchez‐Alcoholado, Aurora Laborda-Illanes, A. Otero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9549-9549
Open Access | Times Cited: 27
Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients
Heidelinde Sammallahti, Arto Kokkola, Sama Rezasoltani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12978-12978
Open Access | Times Cited: 27
Bile Acids and Microbiota Interplay in Pancreatic Cancer
Pratibha Malhotra, Ranjith Palanisamy, José A. Caparrós‐Martín, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3573-3573
Open Access | Times Cited: 11
Epidemiology of pancreatic cancer: New version, new vision
Wenhao Luo, Jun Wang, Hao Chen, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 5, pp. 438-450
Open Access | Times Cited: 11
The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers
Yiyi Zhang, Nie Tang, Hui Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116218-116218
Open Access | Times Cited: 4
Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence
Feng Zhao, Anli Chen, Xiaotian Wu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Relevance of oncobiome in breast cancer evolution in an Argentine cohort
Leonardo Néstor Rubén Dandeu, Joel Lachovsky, Sofía Sidlik, et al.
mSphere (2025)
Open Access
A fluorescence-based assay for measuring aminopropyltransferase activity
Pallavi Singh, Jae‐Yeon Choi, Choukri Ben Mamoun
Methods in enzymology on CD-ROM/Methods in enzymology (2025)
Closed Access
The dual role of gut microbiota in pancreatic cancer: new insights into onset and treatment
Huijuan Cheng, Hongkai Guo, Chunling Wen, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
The Relationship of the Microbiome, Associated Metabolites and the Gut Barrier with Pancreatic Cancer
Neil Daniel, Riccardo Farinella, Flavia Belluomini, et al.
Seminars in Cancer Biology (2025)
Open Access
Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Kousik Kesh, Roberto Méndez, Leila Abdelrahman, et al.
Microbial Cell Factories (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 30
Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut
Qin Yu, Christian Jobin, Ryan M. Thomas
Neoplasia (2021) Vol. 23, Iss. 2, pp. 246-256
Open Access | Times Cited: 26
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development
Ruben Bellotti, Cornelia Speth, Timon E. Adolph, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3431-3431
Open Access | Times Cited: 25
Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers
Mark Stasiewicz, Marek Kwaśniewski, Tomasz M. Karpiński
Cancers (2021) Vol. 13, Iss. 15, pp. 3784-3784
Open Access | Times Cited: 25
Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations
Bartosz Kamil Sobocki, Karolina Kaźmierczak-Siedlecka, Marcin Folwarski, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4425-4425
Open Access | Times Cited: 25
Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
Robert Harrison Hester, Paweł K. Mazur, Florencia McAllister
Clinical Cancer Research (2021) Vol. 27, Iss. 23, pp. 6287-6297
Open Access | Times Cited: 24
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC
Kousik Kesh, Roberto Méndez, Beatriz Mateo-Victoriano, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 3

Scroll to top